An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital

  • K. Graf
  • A. Cohrs
  • P. Gastmeier
  • A. Kola
  • R.-P. Vonberg
  • F. Mattner
  • D. Sohr
  • I. F. Chaberny
Brief Report

References

  1. 1.
    Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, Rossier A, Barbut F, Petit JC (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38:2484–2487PubMedGoogle Scholar
  2. 2.
    Clinical and Laboratory Standards Institute (CLSI) (2007) Methods for antimicrobial susceptibility testing of anaerobic bacteria, approved standard—seventh edition. Guidelines of the CLSI: M11–A7. Available online at: http://www.clsi.org/source/orders/free/m11a7.pdf
  3. 3.
    Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I (2007) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13:1048–1057. doi:10.1111/j.1469-0691.2007.01824.x PubMedCrossRefGoogle Scholar
  4. 4.
    Kuijper EJ, Coignard B, Tüll P (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):2–18. doi:10.1111/j.1469-0691.2006.01580.x PubMedCrossRefGoogle Scholar
  5. 5.
    McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK (2007) Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28:140–145. doi:10.1086/511798 PubMedCrossRefGoogle Scholar
  6. 6.
    Robert Koch Institute (2008) Clostridium difficile: current data on severe cases in Germany. Clostridium difficile: Zum Stand der Meldungen schwer verlaufender Infektionen in Deutschland. Epidemolog Bull 15:117–119Google Scholar
  7. 7.
    Gaynes R, Rimland D, Killum E, Lowery HK, Johnson TM 2nd, Killgore G, Tenover FC (2004) Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38:640–645. doi:10.1086/381551 PubMedCrossRefGoogle Scholar
  8. 8.
    Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45:1543–1549. doi:10.1086/523582 PubMedCrossRefGoogle Scholar
  9. 9.
    Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L (2008) Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 46:1838–1843. doi:10.1086/588291 PubMedCrossRefGoogle Scholar
  10. 10.
    Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P; European C Difficile-Infection Control Group (2008) Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 14(Suppl.5):2–20. doi:10.1111/j.1469-0691.2008.01992.x PubMedCrossRefGoogle Scholar
  11. 11.
    Kleinkauf N, Weiss B, Jansen A, Eckmanns T, Bornhofen B, Küehnen E, Weil HP, Michels H (2007) Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill 12:E071115.2PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • K. Graf
    • 1
  • A. Cohrs
    • 1
  • P. Gastmeier
    • 1
  • A. Kola
    • 1
  • R.-P. Vonberg
    • 1
  • F. Mattner
    • 1
    • 3
  • D. Sohr
    • 2
  • I. F. Chaberny
    • 1
  1. 1.Institute for Medical Microbiology and Hospital EpidemiologyHannover Medical SchoolHannoverGermany
  2. 2.Institute of Hygiene and Environmental MedicineCharité—University Medicine BerlinBerlinGermany
  3. 3.Institute of Medical Microbiology and HygieneUniversity of LübeckLübeckGermany

Personalised recommendations